Ergoline derivatives and their use as chemokine receptor ligands

Details for Australian Patent Application No. 2006254395 (hide)

Owner Novartis AG

Inventors Streiff, Markus; Thoma, Gebhard; Kovarik, Jiri; Baenteli, Rolf; Glickman, Fraser; Zerwes, Hans-Gunter; Lewis, Ian

Agent Davies Collison Cave

Pub. Number AU-B-2006254395

PCT Pub. Number WO2006/128658

Priority 0511060.6 31.05.05 GB

Filing date 29 May 2006

Wipo publication date 7 December 2006

Acceptance publication date 9 September 2010

International Classifications

C07D 457/06 (2006.01) Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

C07D 457/08 (2006.01) Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/128658 Priority application(s): WO2006/128658

9 September 2010 Application Accepted

  Published as AU-B-2006254395

13 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254396-Organic compounds

2006254392-Method of mollusc control